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Background: Coronary artery calcium (CAC) scoring is primarily utilized as a screening test in selected asymptomatic patients. As a measure of 
coronary artery disease (CAD) burden, CAC scoring in symptomatic patients has been recommended in a recent American College of Cardiology 
Expert Statement, but concerns exist about the true prevalence of CAD among symptomatic patients with a CAC score of zero.
Methods: From 24,775 adults without known coronary artery disease undergoing clinically-referred coronary computed tomographic angiography 
(CCTA) at 12 centers in 6 countries, we identified patients who underwent simultaneous CAC (Agatston) scoring. CAD severity was assessed as <50%, 
≥50% and ≥70% lumen stenosis on CCTA. Major adverse events (all death, myocardial infarction and coronary revascularization) were assessed by 
Kaplan Meier and Cox proportional hazards. Events occurring <90 days after the index test were censored.
Results: The study population consisted of 17,528 patients (50% women) of mean age 57 years, with most (89%) presenting with non-typical 
anginal symptoms. CAC was present in 56% (9,782) of patients (mean CAC score of 195 ± 542) and the overall prevalence of any stenosis ≥50% 
was on CCTA was 19%. CAC scoring had an overall sensitivity of 87%, specificity of 54%, negative predictive value of 95% and positive predictive 
value of 31% for the detection of any stenosis ≥50%. Among patients with CAC= 0, 79% had no CAD, 15.5% purely non-obstructive disease and 
5.5% had ≥1 vessel with ≥50% stenosis (3% had ≥70% stenosis), as defined on CCTA. Among 6,596 patients with CAC=0 and complete follow-up 
data, during a median 2.1 (interquartile range 1.5-3.1) years, 4.8% (13/270) of patients with CAC=0 and ≥50% stenosis experienced a late adverse 
event, HR 5.4 (CI 2.9-10.1; p<0.001) adjusted for baseline Framingham risk score, compared to those with no CAC and no obstructive CAD, driven 
primarily by late coronary revascularizations (10/13).
Conclusions: Absence of CAC does not fully exclude the presence of obstructive CAD in patients clinically referred for CCTA. Among symptomatic 
patients with CAC=0, contrast coronary CT angiography provides incremental diagnostic and prognostic information.
